{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:04:50Z","timestamp":1772773490386,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T00:00:00Z","timestamp":1400025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00384-014-1879-x","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T02:41:34Z","timestamp":1399948894000},"page":"835-842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Mattia F.","family":"Osti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Agolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Bracci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Masoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Falco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaliana","family":"De Sanctis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Maurizi Enrici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,14]]},"reference":[{"key":"1879_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/annonc\/mdi098","volume":"16","author":"P Boyle","year":"2005","unstructured":"Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16:481\u2013488","journal-title":"Ann Oncol"},{"key":"1879_CR2","doi-asserted-by":"crossref","unstructured":"Anonymous (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Eng J Med 336:980\u2013987","DOI":"10.1056\/NEJM199704033361402"},{"key":"1879_CR3","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1200\/JCO.2005.08.144","volume":"23","author":"J Folkesson","year":"2005","unstructured":"Folkesson J, Birgisson H, Pahlman L (2005) Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644\u20135650","journal-title":"J Clin Oncol"},{"key":"1879_CR4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(86)91510-2","volume":"1","author":"RJ Heald","year":"1986","unstructured":"Heald RJ, Ryall RDH (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479\u20131482","journal-title":"Lancet"},{"key":"1879_CR5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00000658-200111000-00008","volume":"234","author":"E Rullier","year":"2001","unstructured":"Rullier E, Goffre B, Bonnel C, Zerbib F, Caudry M, Saric J (2001) Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg 234:633\u2013640","journal-title":"Ann Surg"},{"key":"1879_CR6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s10350-004-6545-x","volume":"46","author":"J Garc\u00eda-Aguilar","year":"2003","unstructured":"Garc\u00eda-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA (2003) A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 46:298\u2013304","journal-title":"Dis Colon Rectum"},{"key":"1879_CR7","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","volume":"24","author":"JP G\u00e9rard","year":"2006","unstructured":"G\u00e9rard JP, Conroy T, Bonnetain F, Bouch\u00e9 O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620\u20134625","journal-title":"J Clin Oncol"},{"key":"1879_CR8","doi-asserted-by":"crossref","unstructured":"Meta-analysis in Group Cancer (1998) Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis in Group Cancer. J Clin Oncol 16:301\u2013308","DOI":"10.1200\/JCO.1998.16.1.301"},{"key":"1879_CR9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1634\/theoncologist.12-11-1309","volume":"12","author":"R Glynne-Jones","year":"2007","unstructured":"Glynne-Jones R, Harrison M (2007) Locally advanced rectal cancer: what is the evidence for induction chemoradiation? Oncologist 12:1309\u20131318","journal-title":"Oncologist"},{"key":"1879_CR10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s002800050043","volume":"45","author":"J Sch\u00fcller","year":"2000","unstructured":"Sch\u00fcller J, Cassidy J, Dumont E, Roos B, Durston S, Banken L, Utoh M, Mori K, Weidekamm E, Reigner B (2000) Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 45:291\u2013297","journal-title":"Cancer Chemother Pharmacol"},{"key":"1879_CR11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2005.02.046","volume":"63","author":"JC Kim","year":"2005","unstructured":"Kim JC, Kim TW, Kim JH, Yu CS, Kim HC, Chang HM, Ryu MH, Park JH, Ahn SD, Lee SW, Shin SS, Kim JS, Choi EK (2005) Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in LARC. Int J Radiat Oncol Biol Phys 63:346\u2013353","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1879_CR12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12094-012-0915-y","volume":"15","author":"M Heras de las","year":"2013","unstructured":"de las Heras M, Arias F, del Moral-Avila R, G\u00f3mez-Mill\u00e1n J, Jim\u00e9nez E, Wals A, Tisaire JL, Alcantara MP (2013) Multicentre phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer. Clin Transl Oncol 15:294\u2013299","journal-title":"Clin Transl Oncol"},{"key":"1879_CR13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176\u2013181","journal-title":"Semin Radiat Oncol"},{"key":"1879_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s003840050072","volume":"12","author":"O Dworak","year":"1997","unstructured":"Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Color Dis 12:19\u201323","journal-title":"Int J Color Dis"},{"issue":"suppl 4","key":"1879_CR15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/annonc\/mdp128","volume":"20","author":"B Glimelius","year":"2009","unstructured":"Glimelius B, Oliviera J (2009) Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(suppl 4):54\u201356","journal-title":"Ann Oncol"},{"key":"1879_CR16","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731\u20131740","journal-title":"N Engl J Med"},{"key":"1879_CR17","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","volume":"27","author":"MS Roh","year":"2009","unstructured":"Roh MS, Colangelo LH, O\u2019Connell MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ, Wolmark N (2009) Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27:5124\u20135130","journal-title":"J Clin Oncol"},{"key":"1879_CR18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","volume":"373","author":"D Sebag-Montefiore","year":"2009","unstructured":"Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811\u2013820","journal-title":"Lancet"},{"key":"1879_CR19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC, EORTC Radiotherapy Group Trial 22921 (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114\u20131123","journal-title":"N Engl J Med"},{"key":"1879_CR20","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","volume":"28","author":"JP G\u00e9rard","year":"2010","unstructured":"G\u00e9rard JP, Azria D, Gourgou-Bourgade S, Martel-Laffay I, Hennequin C, Etienne PL, Vendrely V, Fran\u00e7ois E, de La Roche G, Bouch\u00e9 O, Mirabel X, Denis B, Mineur L, Berdah JF, Mah\u00e9 MA, B\u00e9couarn Y, Dupuis O, Lledo G, Montoto-Grillot C, Conroy T (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12\/0405-Prodige 2. J Clin Oncol 28:1638\u20131644","journal-title":"J Clin Oncol"},{"key":"1879_CR21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3109\/0284186X.2011.582880","volume":"50","author":"L Caravatta","year":"2011","unstructured":"Caravatta L, Padula GD, Picardi V, Macchia G, Deodato F, Massaccesi M, Sofo L, Pacelli F, Rotondi F, Cecere G, Sallustio G, Di Lullo L, Piscopo A, Mignogna S, Bonomo P, Cellini N, Valentini V, Morganti AG (2011) Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study. Acta Oncol 50:1151\u20131157","journal-title":"Acta Oncol"},{"key":"1879_CR22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/02841860701798866","volume":"47","author":"LW Vestermark","year":"2008","unstructured":"Vestermark LW, Jacobsen A, Qvortrup C, Hansen F, Bisgaard C, Baatrup G, Rasmussen P, Pfeiffer P (2008) Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT\/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Acta Oncol 47:428\u2013433","journal-title":"Acta Oncol"},{"key":"1879_CR23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/0284186X.2011.652740","volume":"51","author":"LW Vestermark","year":"2012","unstructured":"Vestermark LW, Jensen HA, Pfeiffer P (2012) High-dose radiotherapy (60 Gy) with oral UFT\/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial. Acta Oncol 51:311\u2013317","journal-title":"Acta Oncol"},{"key":"1879_CR24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00384-012-1630-4","volume":"28","author":"R Engineer","year":"2013","unstructured":"Engineer R, Mohandas KM, Shukla PJ, Shrikhande SV, Mahantshetty U, Chopra S, Goel M, Mehta S, Patil P, Ramadwar M, Deodhar K, Arya S, Shrivastava SK (2013) Escalated radiation dose alone vs. concurrent chemoradiation for locally advanced and unresectable rectal cancers: results from phase II randomized study. Int J Color Dis 28:959\u2013966","journal-title":"Int J Color Dis"},{"key":"1879_CR25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ijrobp.2006.05.063","volume":"66","author":"S Krishnan","year":"2006","unstructured":"Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH (2006) Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 66:762\u2013771","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1879_CR26","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s10350-006-0678-z","volume":"49","author":"DY Kim","year":"2006","unstructured":"Kim DY, Kim TH, Jung KH, Chang HJ, Lim SB, Choi HS, Jeong SY, Nam TK, Ryu SY, Lee DS, Choi SI, Kang JH, Yoon SC (2006) Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: a multi-institutional phase II study (KROG 04-01). Dis Colon Rectum 49:1684\u20131691","journal-title":"Dis Colon Rectum"},{"key":"1879_CR27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"W Gijn van","year":"2011","unstructured":"van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, P\u00e5hlman L, Glimelius B, van de Velde CJ, Dutch Colorectal Cancer Group (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575\u2013582","journal-title":"Lancet Oncol"},{"key":"1879_CR28","author":"K McCarthy","year":"2012","unstructured":"McCarthy K, Pearson K, Fulton R, Hewitt J (2012) Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer. Cochrane Database Syst Rev. doi: 10.1002\/14651858.CD008368.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1879_CR29","doi-asserted-by":"crossref","unstructured":"Ceelen WP, Van Nieuwenhove Y, Fierens K (2009) Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev (1). doi: 10.1002\/14651858.CD006041.pub2","DOI":"10.1002\/14651858.CD006041.pub2"},{"key":"1879_CR30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00423-011-0890-8","volume":"397","author":"R Pach","year":"2012","unstructured":"Pach R, Kulig J, Richter P, Gach T, Szura M, Kawalska T (2012) Randomized clinical trial on preoperative radiotherapy 25Gy in rectal cancer\u2014treatment results at 5-year follow up. Langenbeck\u2019s Arch Surg 397:801\u2013807","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"1879_CR31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4251\/wjgo.v4.i12.230","volume":"4","author":"GV Koukourakis","year":"2012","unstructured":"Koukourakis GV (2012) Role of radiation therapy in neoadjuvant era in patients with locally advanced rectal cancer. World J Gastrointest Oncol 4:230\u2013237","journal-title":"World J Gastrointest Oncol"},{"key":"1879_CR32","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/bjs.6739","volume":"96","author":"TE Bernstein","year":"2009","unstructured":"Bernstein TE, Endreseth BH, Romundstad P, Wibe A, Norwegian Colorectal Cancer Group (2009) Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg 96:1348\u20131357","journal-title":"Br J Surg"},{"key":"1879_CR33","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/DCR.0b013e3181b54fbd","volume":"52","author":"HS Tilney","year":"2009","unstructured":"Tilney HS, Rasheed S, Northover JM, Tekkis PP (2009) The influence of circumferential resection margins on long-term outcomes following rectal cancer surgery. Dis Colon Rectum 52:1723\u20131729","journal-title":"Dis Colon Rectum"},{"key":"1879_CR34","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1158\/1078-0432.CCR-07-1197","volume":"13","author":"MJ Gosens","year":"2007","unstructured":"Gosens MJ, Klaassen RA, Tan-Go I, Rutten HJ, Martijn H, van den Brule AJ, Nieuwenhuijzen GA, van Krieken JH, Nagtegaal ID (2007) Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res 13:6617\u20136623","journal-title":"Clin Cancer Res"},{"key":"1879_CR35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ijrobp.2012.01.045","volume":"84","author":"JH Lee","year":"2012","unstructured":"Lee JH, Kim DY, Nam TK, Yoon SC, Lee DS, Park JW, Oh JH, Chang HJ, Yoon MS, Jeong JU, Jang HS (2012) Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-Institutional phase II study (KROG 04-01). Int J Radiat Oncol Biol Phys 84:955\u2013961","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1879_CR36","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1245\/s10434-011-2209-y","volume":"19","author":"L Zorcolo","year":"2012","unstructured":"Zorcolo L, Rosman AS, Restivo A, Pisano M, Nigri GR, Fancellu A, Melis M (2012) Complete pathological response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis. Ann Surg Oncol 19:2822\u20132832","journal-title":"Ann Surg Oncol"},{"key":"1879_CR37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ciresp.2012.07.014","volume":"91","author":"A Codina Cazador","year":"2013","unstructured":"Codina Cazador A, Farres Coll R, Olivet Pujol F, Martin Grillo A, Pujadas de Palol M, G\u00f3mez Romeu N, Julia Bergkvist D, Ortiz Duran R, Diez G\u00f3mez E (2013) Clinical and oncological results of the pathological complete response in rectal cancer after neoadjuvant treatment. Cir Esp 91:417\u2013423","journal-title":"Cir Esp"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-014-1879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-014-1879-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-014-1879-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T09:34:36Z","timestamp":1597829676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-014-1879-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,14]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1879"],"URL":"https:\/\/doi.org\/10.1007\/s00384-014-1879-x","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,14]]}}}